Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 2:2
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 2
2 (50.0%)The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Anderson Clinical Research
- Target Recruit Count
- 60
- Registration Number
- NCT00002385
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
Phase 2
Completed
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Anderson Clinical Research
- Target Recruit Count
- 27
- Registration Number
- NCT00002188
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
Phase 2
Completed
- Conditions
- Mycobacterium Avium-Intracellulare InfectionHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Anderson Clinical Research
- Registration Number
- NCT00002192
- Locations
- 🇺🇸
Hampton Roads Med Specialists, Hampton, Virginia, United States
A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
Not Applicable
Completed
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Anderson Clinical Research
- Registration Number
- NCT00002439
News
No news found